GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market.

GSK's BCMA-directed antibody-drug conjugate Blenrep reduced the risk of death by 42% in a multiple myeloma trial that the company believes could be practice-changing. The DREAMM-7 study showed ...

The best hoodies for men combine comfort and style in one convenient package. These are the GQ-favorite picks every guy needs, from Nike, Uniqlo, and more.

Shopping Tips and Deals Carhartt has Rain Defender hoodies on sale for up to 40% off in a rare Black Friday deal Updated: Jul. 01, 2025, 3:05 p.m. | Published: Nov. 25, 2024, 8:45 p.m.